Questions and answers

How much does quitting smoking lower cancer risk?

How cancer risk falls after you stop, why quitting helps at any age and even after a cancer diagnosis, and which methods really work

Updated: 28 October 20266 min read12 references
Show content for:
Short answer

A great deal. Quitting smoking lowers the risk of at least 12 types of cancer, including cancers of the lung, mouth and throat, oesophagus, bladder, stomach and liver [1]. Lung cancer risk starts to fall within the first few years [5], and overall cancer risk drops to half that of people who keep smoking after about 15 years [4]. Quitting before the age of 40 prevents more than 9 in 10 of the early deaths caused by continuing to smoke, and quitting at any age, even after a cancer diagnosis, helps people live longer [1, 2, 3, 6].

Key points

  • It is never too late: quitting smoking helps at any age and can add up to 10 years of life [1, 3].
  • The sooner, the better: quitting before the age of 40 prevents more than 9 in 10 of the early deaths caused by continuing to smoke [2, 3].
  • Cancer risk falls gradually: lung cancer risk falls within the first few years, and overall cancer risk falls clearly after about 10 to 15 years [4, 5].
  • Even after a cancer diagnosis: patients who stopped smoking lived longer [6].
  • Help raises the chance of success: counselling and medicines such as varenicline or nicotine replacement make quitting more likely [7, 8, 9].
  • Former heavy smokers may need a yearly lung CT scan [11].

How does cancer risk fall after quitting?

Smoking raises the risk of at least 12 types of cancer, and quitting lowers the risk of all of them: lung, larynx, mouth and throat, oesophagus, pancreas, bladder, stomach, bowel, liver, cervix, kidney and a type of blood cancer called acute myeloid leukaemia [1].

This drop does not happen overnight; it grows year by year:

  • Lung cancer: in a long-running study in the United States, heavy smokers who quit had about two fifths less risk of lung cancer within 5 years of quitting than those who kept smoking [5].
  • All cancers: in a study of about 3 million people in South Korea, overall cancer risk fell clearly about 10 years after quitting and, after 15 years, was half that of people who kept smoking. Quitting lowered the risk at every age [4].
  • But the risk never falls quite to zero: even 25 years after quitting, former heavy smokers had more than 3 times the lung cancer risk of people who had never smoked [5]. That is why paying attention to symptoms and screening matters.
How many years of life does quitting at different ages add? (a study of more than 200,000 Americans)
Age at quittingExtra years of life compared with continuing to smoke
25 to 34 yearsAbout 10 years [3]
35 to 44 yearsAbout 9 years [3]
45 to 54 yearsAbout 6 years [3]

In a study of more than one million women in the UK, quitting before the age of 40 also prevented more than 9 in 10 of the early deaths caused by continuing to smoke [2]. Quitting at older ages helps too [1].

If I have cancer, does quitting smoking still help?

Yes, and it matters a lot. In a review of 36 studies of more than 17,000 cancer patients who smoked, those who quit after their diagnosis lived longer, and their cancer came back or progressed less often [6]. Most of these studies were in lung cancer and head and neck cancers, but the benefit of quitting was similar across different cancers [6].

Tell your care team that you smoke and ask them for help to quit; the best time to stop is now, before or during treatment.

Which methods really help people quit?

Getting help makes success much more likely, especially when counselling and medicines are used together [1, 7]:

  • Counselling: face-to-face or telephone sessions with a stop-smoking adviser, and even text-message or online programmes, help people quit [1].
  • Nicotine replacement: nicotine patches, gum or lozenges make quitting about one and a half times more likely [9]. Using a patch together with gum or lozenges works better than one type alone [1].
  • Varenicline: a prescription tablet that more than doubles the chance of quitting. In studies it worked better than a single type of nicotine replacement [8]. Its most common side effect is nausea [12].

Choose the right method with your doctor, who will take your other conditions and medicines into account.

What about e-cigarettes (vapes) for quitting?

Opinions on e-cigarettes still differ. In the latest review of the studies, nicotine e-cigarettes helped people who wanted to stop smoking slightly more than nicotine replacement did; about 4 more people in every 100 quit smoking [10]. No serious short-term harm was seen in these studies, but the long-term effects are not yet known [10].

The US Preventive Services Task Force does not consider the evidence strong enough to recommend e-cigarettes and advises using proven, safe methods first [7]. If you are thinking about them, talk to your doctor before you start.

I used to smoke. Should I be tested for lung cancer?

If you are 50 to 80 years old, have smoked at least 20 "pack-years" (for example, a pack a day for 20 years) and still smoke or quit within the last 15 years, a yearly low-dose CT scan of the lungs is recommended [11]. This test finds lung cancer earlier and lowers the risk of dying from it [11]. Check whether screening is right for you: Should I be screened for lung cancer?

What should I do? One important step: set a quit date and get help

  1. 1

    Choose your quit date

    Pick a date in the near future and tell your family and friends so they can support you.

  2. 2

    Talk to your doctor about medicines and counselling

    Combining counselling with medicines gives the best chance of success [1, 7]. If varenicline is prescribed, it is usually started one week before the quit date [12].

  3. 3

    Give up hookah and opium too

    Hookah is not a safe alternative to cigarettes, and opium also causes cancer; see Does hookah cause cancer? and Does opium cause cancer?

  4. 4

    If you slip, try again

    If you slip or do not succeed the first time, do not give up; trying again is recommended [12]. Make a new plan with your doctor.

Frequently asked questions

How many years after quitting does lung cancer risk become the same as a non-smoker's?

In heavy smokers, usually not completely. The risk falls from the first years, but even 25 years after quitting it was still higher than in people who had never smoked [5]. Even so, every year without cigarettes lowers the risk further [4, 5].

I am 60 and have smoked for many years. Is it still worth quitting?

Yes. Quitting smoking helps at any age and improves health and quality of life [1]. In the Korean study, people who quit after the age of 50 also had a lower lung cancer risk, although the benefit was greater for those who quit earlier [4].

Is cutting down enough?

No. In the study of one million British women, even those who smoked fewer than 10 cigarettes a day died at twice the rate of non-smokers [2]. Cutting down can be a step towards quitting; for people who cannot stop all at once, a doctor can offer a plan to cut down gradually with medicine [12]. The goal is to stop completely.

Is varenicline safe?

Most people tolerate it well. The most common side effect is nausea, which is usually mild; take the tablets after food with a full glass of water [12]. Strange dreams, constipation, wind and vomiting can also occur [12]. If you notice changes in mood, depression or thoughts of harming yourself, stop the medicine and contact your doctor [12].

Does quitting before surgery or chemotherapy help?

Yes. In cancer patients, quitting smoking after diagnosis was linked to longer survival and less cancer recurrence [6]. Talk to your care team about help to quit before treatment starts.

What if I smoke hookah instead of cigarettes?

Hookah is not a safe alternative. See the evidence in Does hookah cause cancer?

For physicians

Details of the evidence and dosing (for physicians)

For physiciansMortality and age at quitting.
For physicians

Mortality and age at quitting. Million Women Study (1.2 million UK women, 12 years): mortality rate ratio 2.76 (2.71 to 2.81) for baseline smokers, 1.98 for fewer than 10 cigarettes a day and 21.4 for lung cancer death. Permanent cessation at 25 to 34 and 35 to 44 years: all-cause mortality RR 1.05 and 1.20, and lung cancer mortality 1.84 and 3.34; stopping before 40 avoids more than 90% and stopping before 30 more than 97% of the excess mortality caused by continued smoking [2]. US NHIS (202,248 people): mortality HR in current smokers 3.0 in women and 2.8 in men; quitting at 25 to 34, 35 to 44 and 45 to 54 years gained about 10, 9 and 6 years of life [3].

Time course of cancer risk. Korean cohort (2,974,820 people, 13.4 years): complete quitters vs continuing smokers, HR 0.83 for all cancers, 0.58 lung, 0.73 liver, 0.86 stomach and 0.80 colorectal; overall risk was slightly higher than in continuing smokers during the first 10 years and fell to 50% of theirs after 15 years or more; lung cancer HR 0.43 when quitting before 50 vs 0.61 after [4]. Framingham (heavy smokers with more than 21.3 pack-years): lung cancer HR vs never-smokers 12.12 at less than 5 years since quitting, 5.88 at 15 to 24 years and 3.85 at 25 years or more; 39.1% lower risk than continuing smokers within 5 years; 40.8% of lung cancers in former smokers occurred more than 15 years after quitting [5].

After diagnosis. Meta-analysis of 36 studies (more than 17,000 patients): cessation at diagnosis was associated with better overall survival (sHR 0.71; 0.65 to 0.78), progression-free survival (0.64) and disease-free/recurrence-free survival (0.59) [6].

Medicines (Cochrane). Varenicline vs placebo RR 2.32 (2.15 to 2.51; high certainty), vs bupropion 1.36 and vs single NRT 1.25; no clear difference vs dual NRT (1.02); cytisine vs placebo 1.30; serious adverse events with varenicline RR 1.23 (1.01 to 1.48), with no clear increase in neuropsychiatric serious adverse events (RR 0.89; low certainty) [8]. Any NRT vs control RR 1.55 (1.49 to 1.61) [9]. USPSTF 2021: behavioural interventions and FDA-approved pharmacotherapy for all non-pregnant adults (grade A) [7].

Varenicline dosing (FDA label). Start one week before the quit date (or quit between days 8 and 35 of treatment): 0.5 mg once daily on days 1 to 3, 0.5 mg twice daily on days 4 to 7, then 1 mg twice daily to complete 12 weeks; a further 12 weeks is recommended for successful quitters. Take after food with a full glass of water. CrCl below 30 mL/min: start at 0.5 mg once daily, maximum 0.5 mg twice daily; haemodialysis: maximum 0.5 mg once daily. Nausea 30% vs 10% on placebo. Monitor for neuropsychiatric symptoms [12].

E-cigarettes. Cochrane 2026 (80 trials, 29,861 participants): nicotine EC vs NRT RR 1.61 (1.23 to 2.12; high certainty), about 4 additional quitters per 100; similar serious adverse events; long-term safety unknown, and only regulated products were studied [10]. The USPSTF 2021 and the 2020 Surgeon General's report judged the evidence insufficient to recommend them [1, 7].

Screening. Annual LDCT for people aged 50 to 80 with ≥20 pack-years who currently smoke or quit within the past 15 years (USPSTF 2021, grade B) [11].

Scientific evidence

Scientific evidence

3 items
Clinical guideline

Screening for Lung Cancer

JAMA · 2021
228,820 peopleNew lung cancer diagnoses in the United States (2020, estimate)
Clinical trial

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

N Engl J Med · 2011
20.0%Relative reduction in lung cancer deaths
Clinical trial

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

N Engl J Med · 2020
0.76Cumulative rate ratio for lung cancer death at 10 years (men)

References

12 references
Show all references, 1 with a study cardClose the reference list

Numbers in the text, such as [1], refer to these sources. Sources with a “Study card” button are summarised in the site’s evidence library.

  1. 1
    Smoking Cessation: A Report of the Surgeon GeneralUS Department of Health and Human Services · US Department of Health and Human Services (NCBI Bookshelf NBK555591) · 2020
    Source Back to text: 1 2 3 4 5 6 7 8 9 10 11
  2. 2
    The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UKPirie K, Peto R, Reeves GK, et al · Lancet · 2013;381:133-41
    DOIPubMed Back to text: 1 2 3 4 5
  3. 3
    21st-century hazards of smoking and benefits of cessation in the United StatesJha P, Ramasundarahettige C, Landsman V, et al · N Engl J Med · 2013;368:341-50
    DOIPubMed Back to text: 1 2 3 4 5 6 7
  4. 4
    Cancer Risk Following Smoking Cessation in KoreaPark E, Kang HY, Lim MK, et al · JAMA Netw Open · 2024;7:e2354958
    DOIPubMed Back to text: 1 2 3 4 5 6
  5. 5
    Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart StudyTindle HA, Stevenson Duncan M, Greevy RA, et al · J Natl Cancer Inst · 2018;110:1201-1207
    DOIPubMed Back to text: 1 2 3 4 5 6 7
  6. 6
    Upgrading your best chances: postdiagnosis smoking cessation boosts life expectancy of patients with cancer - a systematic review and meta-analysisCaini S, Gorini G, Del Riccio M, et al · Tob Control · 2025
    DOIPubMed Back to text: 1 2 3 4 5 6
  7. 7
    Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation StatementKrist AH, Davidson KW, Mangione CM, et al · JAMA · 2021;325:265-279
    DOIPubMed Back to text: 1 2 3 4 5 6
  8. 8
    Nicotine receptor partial agonists for smoking cessationLivingstone-Banks J, Fanshawe TR, Thomas KH, et al · Cochrane Database Syst Rev · 2023;5:CD006103
    DOIPubMed Back to text: 1 2 3
  9. 9
    Nicotine replacement therapy versus control for smoking cessationHartmann-Boyce J, Chepkin SC, Ye W, et al · Cochrane Database Syst Rev · 2018;5:CD000146
    DOIPubMed Back to text: 1 2 3
  10. 10
    Electronic cigarettes for smoking cessationLindson N, Livingstone-Banks J, Butler AR, et al · Cochrane Database Syst Rev · 2026;8:CD010216
    DOIPubMed Back to text: 1 2 3
  11. 11
    Screening for Lung Cancer: US Preventive Services Task Force Recommendation StatementKrist AH, Davidson KW, Mangione CM, et al · JAMA · 2021;325:962-970
    Study cardDOIPubMed Back to text: 1 2 3 4
  12. 12
    CHANTIX (varenicline tartrate) tablets: Prescribing InformationPfizer Laboratories · DailyMed, U.S. National Library of Medicine · 2026
    Source Back to text: 1 2 3 4 5 6 7 8

This page is based on reputable scientific sources and was last updated on 28 October 2026. The content of this website is for educational and informational purposes only and does not replace consultation, diagnosis or treatment by a specialist physician. Consult your treating physician about any treatment decision.